Detalhe da pesquisa
1.
A Phase 3, double-blind, placebo-controlled efficacy and safety study of ADS-5102 (Amantadine) extended-release capsules in people with multiple sclerosis and walking impairment.
Mult Scler
; 28(5): 817-830, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34449295
2.
Safety and efficacy of ADS-5102 (amantadine) extended release capsules to improve walking in multiple sclerosis: A randomized, placebo-controlled, phase 2 trial.
Mult Scler
; 25(4): 601-609, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29368539
3.
Patient-Reported Outcome Assessments as Endpoints in Studies in Infectious Diseases.
Clin Infect Dis
; 63 Suppl 2: S52-6, 2016 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27481954
4.
Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program.
Clin Infect Dis
; 62(11): 1380-1389, 2016 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26962078
5.
Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials.
J Antimicrob Chemother
; 71(4): 862-70, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26702925
6.
Evaluation of the effect of a supratherapeutic dose of intravenous ceftaroline fosamil on the corrected QT interval.
Antimicrob Agents Chemother
; 57(4): 1777-83, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23357764
7.
CANVAS 1 and 2: analysis of clinical response at day 3 in two phase 3 trials of ceftaroline fosamil versus vancomycin plus aztreonam in treatment of acute bacterial skin and skin structure infections.
Antimicrob Agents Chemother
; 56(5): 2231-6, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22314524
8.
Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesia.
Front Neurol
; 13: 846126, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36341088
9.
Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials.
J Antimicrob Chemother
; 71(6): 1748-9, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27076104
10.
FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.
J Antimicrob Chemother
; 66 Suppl 3: iii33-44, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21482568
11.
FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.
J Antimicrob Chemother
; 66 Suppl 3: iii19-32, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21482566
12.
Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia.
Clin Infect Dis
; 51(12): 1395-405, 2010 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21067350
13.
Macrolide therapy for community-acquired pneumonia due to atypical pathogens: outcome assessment at an early time point.
Int J Antimicrob Agents
; 50(2): 247-251, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28599867
14.
Efficacy of ceftaroline fosamil for bacteremia associated with community-acquired bacterial pneumonia.
Hosp Pract (1995)
; 42(1): 75-8, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24566599
15.
Assessment of ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia due to Streptococcus pneumoniae: insights from two randomized trials.
Diagn Microbiol Infect Dis
; 75(3): 298-303, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23357290
16.
Panton-Valentine leukocidin is not the primary determinant of outcome for Staphylococcus aureus skin infections: evaluation from the CANVAS studies.
PLoS One
; 7(5): e37212, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22623995